Diabetes mellitus increases risk of adverse drug reactions and death in hospitalised older people : the SENATOR trial

Chinmayee, AnaghaSubbarayan, SelvaraniMyint, Phyo KyawCruz-Jentoft, Alfonso J.Petrovic, MirkoGudmundsson, AdalsteinnByrne, StephenO'Mahony, DenisSoiza, RoyCherubini, Antonio2024-01-292024-01-292024-02Chinmayee, A, Subbarayan, S, Myint, P K, Cruz-Jentoft, A J, Petrovic, M, Gudmundsson, A, Byrne, S, O'Mahony, D, Soiza, R & Cherubini, A 2024, 'Diabetes mellitus increases risk of adverse drug reactions and death in hospitalised older people : the SENATOR trial', European Geriatric Medicine, vol. 15, pp. 189-199. https://doi.org/10.1007/s41999-023-00903-w1878-7657ORCID: /0000-0002-1397-4272/work/149375947unpaywall: 10.1007/s41999-023-00903-wORCID: /0000-0003-3852-6158/work/163198806ORCID: /0000-0002-0322-9244/work/171448021https://hdl.handle.net/2164/22656Funding Information: The SENATOR trial was funded by the European Union Framework Programme 7 (FP7/2007– 2013 grant number 305930) and AC received the Innes Will Endowed Scholarship under the University of Aberdeen Summer Research Scholarship Programme to undertake the present study.11460946601858engSDG 3 - Good Health and Well-beingAdverse drug reactionsDiabetes mellitusMultimorbidityOlder peoplePolypharmacyR MedicineGeriatrics and GerontologyGerontologyEuropean Commission305930Supplementary DataRDiabetes mellitus increases risk of adverse drug reactions and death in hospitalised older people : the SENATOR trialJournal article10.1007/s41999-023-00903-whttp://www.scopus.com/inward/record.url?scp=85180234283&partnerID=8YFLogxK15